Multidisciplinary Management of Advanced or Recurrent Salivary Cancer

This case-based panel will outline the multidisciplinary approach to patients with salivary cancer.  Perspective will be provided by experts in the field on topics such as extent of primary tumor surgery and management of cervical lymphatics, as well as indications for adjuvant radiation therapy and the use of targeted therapy.  This session will outline the available evidence on these topics and also allow for open discussion on these and other controversial topics within the field of salivary cancer management.

 

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Outline the extent of surgery needed for the primary tumor and involved and at-risk cervical lymphatics following this panel.
  • Describe indications for adjuvant radiotherapy in the management of salivary cancer.
  • Describe the evolving role of targeted therapy in the management of salivary cancer.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
03/11/2024
Course expires: 
03/10/2026
Cost:
$0.00
Part of: 
2024 Multidisciplinary Head and Neck Cancers Symposium onDemand
Rating: 
0

Michael Moore, MD, is employed by the Indiana University School of Medicine and has no financial relationships with a commercial interest.

Samer Al-Khudari, MD, is employed by Rush University Medical Center and receives compensation from Zoll Medical. He serves in a leadership position with SAMS.

Annie Chan, MD, is employed by Harvard Medical School and has no financial relationships with a commercial interest.

Renata Ferratto, MD, is employed by MD Anderson Cancer Center and received honoraria/travel expenses/advisory board compensation from Answers in CME, Coherus, Eisai, Elevar, Labcorp, Prelude, Regeneron, Remix and Sanofi.

All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.